banner
vikash24.bsky.social
@vikash24.bsky.social
Postdoc @ Hebrew university.
Studying genomics to find metabolic vulnerabilities in cancer. Interested in everything that affects human health💓 Dogs, mountains, beaches and Yoga.
Reposted
Nature research paper: Lymph node environment drives FSP1 targetability in metastasizing melanoma

go.nature.com/49yHIAk
Lymph node environment drives FSP1 targetability in metastasizing melanoma - Nature
Targeting FSP1 in lymph nodes has considerable potential for blocking melanoma progression.
go.nature.com
November 6, 2025 at 11:01 AM
Reposted
Reposted
Happy 158th Birthday, Marie Skłodowska Curie! She was the first woman to receive a Nobel Prize and the first person to receive the honor twice.

In 2017, #ScienceBooks toured the dynamics that established her as "the most iconic of all female scientists." https://scim.ag/47tkKYA
The making and remaking of Marie Curie
The famous physicist's legacy looms large 150 years after her birth
www.science.org
November 7, 2025 at 2:47 PM
Reposted
In praise of fundamental research
Our editorial this week argues that I n these financially straitened times, funders must recognize that great discoveries often arise from work that was looking for something completely different
🧪
@nature.com
www.nature.com/articles/d41...
From MRI to Ozempic: breakthroughs that show why fundamental research must be protected
In these financially straitened times, funders must recognize that great discoveries often arise from work that was looking for something completely different.
www.nature.com
October 30, 2025 at 1:53 PM
Reposted
John Gurdon, former Group Leader and Head of @cellbiol-mrclmb.bsky.social has died.
Despite calling himself a "total non-intellectual” his work to reprogramme somatic cells to pluripotent stem cells transformed the field of developmental biology.
More: www2.mrc-lmb.cam.ac.uk/john-gurdon-...
#LMBNews
October 8, 2025 at 8:49 AM
Reposted
BREAKING: The Nobel Prize in Physiology or Medicine has been awarded jointly to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi "for their discoveries concerning peripheral immune tolerance"

Stay tuned for more.
#NobelPrize
October 6, 2025 at 9:34 AM
Reposted
Nature research paper: Multiple oestradiol functions inhibit ferroptosis and acute kidney injury

go.nature.com/45Ky3Et
Multiple oestradiol functions inhibit ferroptosis and acute kidney injury - Nature
17β-oestradiol establishes an anti-ferroptotic state in female kidney tubules.
go.nature.com
August 16, 2025 at 12:46 PM
Reposted
#Throwback 🧪

REVIEW | Adipose tissue as a linchpin of organismal ageing

T Nguyen & S Corvera
Adipose tissue as a linchpin of organismal ageing - Nature Metabolism
Nguyen and Corvera review distinct changes that occur in adipose tissue during ageing, discuss potential mechanisms by which these changes impact whole-body metabolism, immunity and longevity, and highlight therapeutic opportunities.
bit.ly
August 7, 2025 at 4:02 PM
Reposted
The story of the discovery of monoclonal antibodies 50 years ago shows how the free exchange of ideas can lead to life-changing treatments

go.nature.com/45GeSM0
Monoclonal antibodies revolutionized biomedical science and health care
The story of the discovery of these molecules 50 years ago shows how the free exchange of ideas can lead to life-changing treatments.
go.nature.com
August 7, 2025 at 3:55 PM
Reposted
1/Patient-derived xenografts (PDXs) are used in preclinical testing of cancer therapies, including metabolic therapies. We determined which metabolic properties are retained, and which are lost, when melanomas from patients are implanted and passaged as PDXs in mice.
www.nature.com/articles/s42...
Conservation and divergence of metabolic phenotypes between patient tumours and matched xenografts - Nature Metabolism
Rao and Cai et al. perform a detailed metabolic comparison between primary tumours from patients and their matching xenografts, which identify conserved as well as divergent metabolic patterns.
www.nature.com
July 29, 2025 at 2:56 PM
Reposted
💫The July issue of @natgenet.nature.com is out!

Featuring:

✅retrotransposons in limb malformation and cancer
✅single-cell Micro-C
✅long-term effects of chemotherapy on normal blood cells
✅blood regulatory variation map in South Africans

And more!

⬇️

www.nature.com/ng/volumes/5...
July 24, 2025 at 2:50 PM
So it’s not just chromosomes—God checks the iron levels too🤭
June 8, 2025 at 8:01 PM
Reposted
Repeated damage from extreme heat over time seems to be a leading factor causing kidneys to fail

https://go.nature.com/3Ze2sri
How a mysterious epidemic of kidney disease is killing thousands of young men
Nature - Repeated damage from extreme heat over time seems to be a leading factor causing kidneys to fail.
go.nature.com
June 6, 2025 at 8:13 AM
Reposted
Nature research paper: Multigenerational cell tracking of DNA replication and heritable DNA damage

https://go.nature.com/4jxWDMJ
Multigenerational cell tracking of DNA replication and heritable DNA damage - Nature
A multigenerational single-cell tracking approach provides a framework to dissect phenotypic plasticity at the single-cell level, offering insights into cellular processes that may resemble early events during cancer development.
go.nature.com
May 23, 2025 at 12:31 PM
Reposted
Join for the first FASEB Ferroptosis conference in the US this July! This stellar speaker line up brings together almost all leaders in the field!
Reminder: The 1st FASEB #Ferroptosis Meeting is this summer! Spectacular speaker lineup + short talks selected from submitted abstracts. It is going to be awesome! Trainees, newcomers & all interested are welcome!
📅 Abstract deadline: June 1, 2025.
shorturl.at/QA6T1
May 4, 2025 at 1:44 AM
Reposted
We've just published our new Cancer supplement for @nature.com, which features four impressive young researchers - @oriolpich.bsky.social @frogsandstars.bsky.social

go.nature.com/4iwN7c8
Four rising stars at the forefront of cancer research
These scientists are coming at cancer from all angles.
www.nature.com
April 24, 2025 at 1:31 AM
Reposted
📰 hot off the press in #NatureMedicine & presented today at #GI25: The phase 3 #BREAKWATER trial in patients w/ BRAFV600E metastatic #ColorectalCancer
🗝️ finding: Encorafenib + cetuximab + mFOLFOX6 ⬆️ ORR vs standard of care
www.nature.com/articles/s41...
#OncSky #CRCSM @natureportfolio.bsky.social
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial - Nature Medicine
As presented at the 2025 ASCO GI Cancers Symposium: in the phase 3 BREAKWATER trial, patients with previously untreated BRAF V600E metastatic colorectal cancer received the BRAF inhibitor encorafenib,...
www.nature.com
January 25, 2025 at 9:12 PM